Julie Jensen is a Senior Consultant at Nimitt Consulting, where she partners with payers, providers, and biotechnology clients to expand access to cellular, gene, and transplant services.
She brings more than 25 years of payer-side experience focused on complex conditions, with leadership roles in clinical consulting, operations, product development, and Centers of Excellence programs at Humana, Claritev (formerly Multiplan), and Optum. This foundation gives her a unique perspective on how payer strategies shape access and reimbursement for high-cost therapies.
Julie is an active member of leading transplant and cell therapy societies and has helped shape advisory panels and publications focused on access, equity, and reimbursement. Julie is also a strong advocate for the Transplant Payer Collaborative, currently serving on its steering committee and the Executive Committee for AST’s Transplant Administrators and Quality Management COP.
